Picture of virus under microscope

Research under the microscope...

The Strathprints institutional repository is a digital archive of University of Strathclyde research outputs.

Strathprints serves world leading Open Access research by the University of Strathclyde, including research by the Strathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS), where research centres such as the Industrial Biotechnology Innovation Centre (IBioIC), the Cancer Research UK Formulation Unit, SeaBioTech and the Centre for Biophotonics are based.

Explore SIPBS research

Functional chracterization of alpha(1)-adrenoceptor subtypes in human skeletal muscle resistance arteries

Jarajapu, Y.P. and Coats, Paul and McGrath, John C. and Hillier, Chris and MacDonald, Allan (2001) Functional chracterization of alpha(1)-adrenoceptor subtypes in human skeletal muscle resistance arteries. British Journal of Pharmacology, 133 (5). pp. 679-686. ISSN 0007-1188

Full text not available in this repository. (Request a copy from the Strathclyde author)

Abstract

alpha (1)-adrenoceptor subtypes in human skeletal muscle resistance arteries were characterized using agonists noradrenaline (non-selective) and A61603 (alpha (1A)-selective), the antagonists prazosin (non-selective), 5-methyl-urapidil (alpha (1A)-selective) and BMY7378 (alpha (1D)-selective) and the alkylating agent chloroethylclonidine (Dreferential for alpha (1B)). Small arteries were obtained from the non-ischaemic skeletal muscle of limbs amputated for critical limb ischaemia and isometric tension recorded using wire myography. Prazosin antagonized responses to noradrenaline with a pA(2) value of 9.18, consistent with the presence of alpha (1)-adrenoceptors, although the Schild slope (1.32) was significantly different from unity. 5-Methyl-urapidil competitively antagonized responses to noradrenaline with a pK(B) value of 8.48 and a Schild slope of 0.99, consistent with the presence of alpha (1A)-adrenoceptors. In the presence of 300 nM. 5-methyl-urapidil, noradrenaline exhibited biphasic concentration response curves, indicating the presence of a minor population of a 5-methyl-urapidil-resistant subtype. Contractile responses to noradrenaline were not affected by 1 muM chloroethylclonidine suggesting the absence of alpha (1B)-adrenoceptors. Maximum responses to noradrenaline and A61603 were reduced to a similar extent by 10 muM chloroethylclonidine, suggesting an effect of chloroethylcionidine at alpha (1A)-adrenoceptors at the higher concentration. BMY7378 (10 and 100 nM) had no effect on responses to noradrenaline. BMY7378 (1 muM) poorly shifted the potency of noradrenaline giving a pA(2) of 6.52. These results rule out the presence of the alu-subtype. These results show that contractile responses to noradrenaline in human skeletal muscle resistance arteries are predominantly mediated by the alpha (1A)-adrenoceptor subtype with a minor population of an unknown alpha (1)-adrenoceptor subtype.